These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 17374814)

  • 21. One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.
    Smolderen KG; Bell A; Lei Y; Cohen EA; Steg PG; Bhatt DL; Mahoney EM;
    Can J Cardiol; 2010 Oct; 26(8):297-305. PubMed ID: 20931098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
    Boden WE; Cherr GS; Eagle KA; Cannon CP; Califf RM; Hirsch AT; Alberts MJ; Criqui M; Creager MA; Massaro JM; D'Agostino RB; Steg PG; Bhatt DL;
    Crit Pathw Cardiol; 2010 Sep; 9(3):116-25. PubMed ID: 20802264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.
    Ruff CT; Bhatt DL; Steg PG; Gersh BJ; Alberts MJ; Hoffman EB; Ohman EM; Eagle KA; Lip GY; Goto S;
    Int J Cardiol; 2014 Jan; 170(3):413-8. PubMed ID: 24321327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management and Outcomes Among Chinese Hospitalized Patients With Established Cardiovascular Disease or Multiple Risk Factors.
    Yang J; Yang Y; Gu H; Li W; Hu D
    Angiology; 2016 Feb; 67(2):168-73. PubMed ID: 25922196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
    Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry.
    Aichner FT; Topakian R; Alberts MJ; Bhatt DL; Haring HP; Hill MD; Montalescot G; Goto S; Touzé E; Mas JL; Steg PG; Röther J;
    Eur J Neurol; 2009 Aug; 16(8):902-8. PubMed ID: 19473362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Eisen A; Bhatt DL; Steg PG; Eagle KA; Goto S; Guo J; Smith SC; Ohman EM; Scirica BM;
    J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease.
    Bergmark BA; Bhatt DL; Braunwald E; Morrow DA; Steg PG; Gurmu Y; Cahn A; Mosenzon O; Raz I; Bohula E; Scirica BM
    Diabetes Care; 2018 Mar; 41(3):577-585. PubMed ID: 29196298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
    Mahoney EM; Wang K; Cohen DJ; Hirsch AT; Alberts MJ; Eagle K; Mosse F; Jackson JD; Steg PG; Bhatt DL;
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):38-45. PubMed ID: 20031786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
    Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
    JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.
    Abola MT; Bhatt DL; Duval S; Cacoub PP; Baumgartner I; Keo H; Creager MA; Brennan DM; Steg PG; Hirsch AT;
    Atherosclerosis; 2012 Apr; 221(2):527-35. PubMed ID: 22321872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
    Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
    Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
    Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
    Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registry.
    Goto S; Ikeda Y; Chan JC; Wilson PW; Yeo TC; Liau CS; Abola MT; Salette G; Steg PG; Bhatt DL
    Heart Asia; 2011; 3(1):93-8. PubMed ID: 27326003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis.
    Sirimarco G; Amarenco P; Labreuche J; Touboul PJ; Alberts M; Goto S; Rother J; Mas JL; Bhatt DL; Steg PG;
    Stroke; 2013 Feb; 44(2):373-9. PubMed ID: 23306325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.
    Parhofer KG; Zeymer U; Stark RG; Binz C; Schwertfeger M; Bhatt DL; Steg PG; Röther J;
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):51-6. PubMed ID: 19834877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.
    Zeymer U; Parhofer KG; Pittrow D; Binz C; Schwertfeger M; Limbourg T; Röther J
    Clin Res Cardiol; 2009 Apr; 98(4):249-56. PubMed ID: 19221687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry.
    Darmon A; Bhatt DL; Elbez Y; Aboyans V; Anand S; Bosch J; Branch KR; Connolly SJ; Dyal L; Eikelboom JW; Fox KAA; Keltai K; Probstfield J; Yusuf S; Abtan J; Sorbets E; Eagle KA; Ducrocq G; Steg PG
    Eur Heart J; 2018 Mar; 39(9):750-757a. PubMed ID: 29186454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.